The CRI Cancer Immunotherapy Consortium (CIC) contributes to the creation of white papers, response documents, and peer-reviewed publications advancing novel outcomes from workshops that seek practical solutions to today's challenges in cancer immunotherapy development.
Publications prior to 2010 are credited to the Cancer Vaccine Consortium, the former name of the Cancer Immunotherapy Consortium.
A browser plugin may be required for the PDF file found this page.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
This April for Esophageal Cancer Awareness Month, we look at new research, new treatments, and how we’re working toward a future immune to esophageal cancer.
Spring equinox marks a moment of renewal. Why not choose a personal goal to invest in yourself and the world around you? Join ’21 Challenge for Cancer Research.